Impact of direct-acting antiviral therapy for hepatitis C–related hepatocellular carcinoma

With the introduction of direct-acting antiviral (DAA) agents, hepatitis C virus (HCV) treatment has dramatically improved. However, there are insufficient data on the benefits of DAA therapy in hepatocellular carcinoma (HCC). The purpose of this study was to investigate the outcome of patients who...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:PLoS One
Autors principals: Lin, Wei-Chen, Lin, Yang-Sheng, Chang, Chen-Wang, Chang, Ching-Wei, Wang, Tsang-En, Wang, Horng-Yuan, Chen, Ming-Jen
Format: Artigo
Idioma:Inglês
Publicat: Public Library of Science 2020
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7244104/
https://ncbi.nlm.nih.gov/pubmed/32442193
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0233212
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars